Search Results 231-240 of 12390 for Raised CEA

  1. Neurology - Clinical trials - Mayo Clinic

    This combination should result in enhanced orthostatic release of NE. The investigators have already demonstrated that pyridostigmine does not raise supine ...

  2. Neurology - Clinical trials

    This combination should result in enhanced orthostatic release of NE. The investigators have already demonstrated that pyridostigmine does not raise supine ...

  3. Neurology - Clinical trials - Mayo Clinic

    This combination should result in enhanced orthostatic release of NE. The investigators have already demonstrated that pyridostigmine does not raise supine ...

  4. Neurology - Clinical trials - Mayo Clinic

    This combination should result in enhanced orthostatic release of NE. The investigators have already demonstrated that pyridostigmine does not raise supine ...

  5. Neurology - Clinical trials

    This combination should result in enhanced orthostatic release of NE. The investigators have already demonstrated that pyridostigmine does not raise supine ...

  6. Neurology - Clinical trials - Mayo Clinic

    This combination should result in enhanced orthostatic release of NE. The investigators have already demonstrated that pyridostigmine does not raise supine ...

  7. Metastatic (stage 4) prostate cancer - Diagnosis and treatment - Mayo Clinic

    Other hormone therapy risks include an increased chance of getting diabetes and heart disease. Chemotherapy for metastatic prostate cancer. Chemotherapy ...

  8. A Study Of The Influence Of Central Obesity On The Esophageal Epithelial Barrier - Mayo Clinic

    This study is being done to help understand why some people with an increased amount of central obesity, without gastroesophageal reflux, develop changes to ...

  9. Neurology - Clinical trials

    This combination should result in enhanced orthostatic release of NE. The investigators have already demonstrated that pyridostigmine does not raise supine ...

  10. Viral Therapy In Treating Patients With Recurrent Glioblastoma Multiforme - Mayo Clinic

    Normal serum CEA level (< ng/ml) at the time of registration; Recurrent grade 4 astrocytoma and grade 4 gliosarcoma with histological confirmation at primary ...